Literature DB >> 27814880

Commentary on "RNA biomarkers associated with metastatic progression in prostate cancer: A multi-institutional high-throughput analysis of SChLAP1." Prensner JR, Zhao S, Erho N, Schipper M, Iyer MK, Dhanasekaran SM, Magi-Galluzzi C, Mehra R, Sahu A, Siddiqui J, Davicioni E, Den RB, Dicker AP, Karnes RJ, Wei JT, Klein EA, Jenkins RB, Chinnaiyan AM, Feng FY, University of Washington-Urology, Seattle, WA. Lancet Oncol 2014; 15(13):1469-80.

Daniel Lin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27814880     DOI： 10.1016/j.urolonc.2016.02.006

Source DB:  PubMed          Journal:  Urol Oncol        ISSN： 1078-1439            Impact factor:   3.498


× No keyword cloud information.
  4 in total

1.  The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promotes melanoma cell proliferation and tumor growth.

Authors:  Cibele Cardoso; Rodolfo B Serafim; Akinori Kawakami; Cristiano Gonçalves Pereira; Jason Roszik; Valeria Valente; Vinicius L Vazquez; David E Fisher; Enilza M Espreafico
Journal:  Pigment Cell Melanoma Res       Date:  2018-12-16       Impact factor: 4.693

2.  Glycan Stimulation Enables Purification of Prostate Cancer Circulating Tumor Cells on PEDOT NanoVelcro Chips for RNA Biomarker Detection.

Authors:  Mo-Yuan Shen; Jie-Fu Chen; Chun-Hao Luo; Sangjun Lee; Cheng-Hsuan Li; Yung-Ling Yang; Yu-Han Tsai; Bo-Cheng Ho; Li-Rong Bao; Tien-Jung Lee; Yu Jen Jan; Ya-Zhen Zhu; Shirley Cheng; Felix Y Feng; Peilin Chen; Shuang Hou; Vatche Agopian; Yu-Sheng Hsiao; Hsian-Rong Tseng; Edwin M Posadas; Hsiao-Hua Yu
Journal:  Adv Healthc Mater       Date:  2017-09-11       Impact factor: 9.933

Review 3.  Urinary markers aiding in the detection and risk stratification of prostate cancer.

Authors:  Nicholas Raja; Christopher M Russell; Arvin K George
Journal:  Transl Androl Urol       Date:  2018-09

4.  Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma.

Authors:  Lu Lu; Le-Ping Liu; Qiang-Qiang Zhao; Rong Gui; Qin-Yu Zhao
Journal:  Front Oncol       Date:  2021-06-23       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.